What Is a Type II Error?
A Type II error occurs when a statistical test fails to reject a false null hypothesis, you conclude that no effect exists when one actually does. It's a false negative. If a new ad creative genuinely outperforms the control but your test says "no significant difference," that's a Type II error. The probability of this mistake is called beta (β), and the complement, 1 - β, is called statistical power. Most researchers target a power of 0.80, which means they accept a 20% chance (β = 0.20) of missing a real effect. Type II errors are less discussed than Type I errors, but in many business contexts, they're more costly: you're walking away from something that works.
Why Type II Errors Matter
Type I errors get most of the attention because they lead to visible mistakes, launching something that doesn't work. Type II errors are invisible. You killed a concept, shelved a campaign, or abandoned a product improvement that would have succeeded. Nobody writes a case study about the thing they didn't launch.
The financial cost can be substantial. If a product reformulation would have increased market share by 2 points, but your underpowered test failed to detect the improvement, you've lost millions in potential revenue. And you don't even know you've lost it, the test said "no difference," and everyone moved on.
Type II errors are particularly dangerous in competitive markets. If your test misses a genuine advantage, your competitor's test might not. They launch the improvement. You don't.
How Type II Errors Work
Beta and Statistical Power
Beta (β) is the probability of a Type II error. Power is 1 - β, the probability of correctly detecting a real effect.
| Power Level | Beta (Type II Error Rate) | Interpretation |
|---|---|---|
| 0.60 | 0.40 | 40% chance of missing a real effect, risky |
| 0.80 | 0.20 | 20% chance of missing a real effect, standard target |
| 0.90 | 0.10 | 10% chance, used for high-stakes studies |
| 0.95 | 0.05 | 5% chance, pharmaceutical and clinical research |
Most market research studies target power = 0.80 as a practical balance between sample cost and detection ability.
What Determines Power?
Statistical power depends on four interconnected factors:
1. Sample size (n): larger samples give you more power. This is the factor you have the most control over.
2. Effect size: larger real differences are easier to detect. A one-point difference on a 10-point scale is harder to find than a three-point difference.
3. Alpha level (α): a stricter alpha (e.g., 0.01 instead of 0.05) reduces power because you're raising the bar for significance.
4. Variability in the data: higher variance means more noise, which makes it harder to detect the signal.
Worked Example: Power and Sample Size
Suppose you're planning a concept test comparing two product designs. You expect a medium effect size (Cohen's d = 0.50) and want power = 0.80 at α = 0.05 using a two-tailed independent t-test.
The required sample size per group can be approximated using:
n = ((z_alpha/2 + z_beta) / d)^2 * 2
Where z_alpha/2 = 1.96 (for α = 0.05, two-tailed) and z_beta = 0.84 (for power = 0.80).
n = ((1.96 + 0.84) / 0.50)^2 * 2 n = (2.80 / 0.50)^2 * 2 n = (5.60)^2 * 2 n = 31.36 * 2 n = 62.72
You'd need approximately 63 respondents per group (126 total) to have an 80% chance of detecting a medium effect.
What happens if you only have 30 per group? Your power drops to roughly 0.48, meaning there's a 52% chance of missing a real medium-sized effect. You'd essentially be flipping a coin on detection.
| n per Group | Power (d = 0.50, α = 0.05) | Type II Error Risk |
|---|---|---|
| 20 | 0.34 | 66% |
| 30 | 0.48 | 52% |
| 50 | 0.70 | 30% |
| 64 | 0.80 | 20% |
| 100 | 0.94 | 6% |
The Type I / Type II Trade-Off
Type I and Type II errors pull in opposite directions. Making alpha stricter (reducing false positives) increases beta (more false negatives). Making alpha more lenient (reducing false negatives) increases the false-positive rate.
The only way to reduce both simultaneously is to increase sample size. With more data, you can maintain a strict alpha while still having enough power to detect real effects.
Here's how the trade-off works for a fixed sample of n = 50 per group, d = 0.50:
| Alpha (α) | Type I Error Risk | Power | Type II Error Risk (β) |
|---|---|---|---|
| 0.10 | 10% | 0.78 | 22% |
| 0.05 | 5% | 0.70 | 30% |
| 0.01 | 1% | 0.50 | 50% |
At α = 0.01 with this sample, you've cut the false-positive rate to 1% but you now have a coin-flip chance of missing a real effect. This is why overly strict alpha levels without correspondingly large samples are a problem.
Real-World Consequences
Product development: A CPG company tested a new formulation against the original with n = 40 per cell. The new version scored 0.4 points higher on a 10-point liking scale, but the test came back non-significant (p = 0.18). The team scrapped the reformulation. A power analysis later revealed the study had only 25% power to detect a difference that small, they needed 200+ per cell.
Pricing research: A subscription service tested a $2/month price increase with a small panel. No significant drop in renewal intent was found, so they implemented the increase. But the study was underpowered for detecting a 3-4% decline, the actual churn increase became visible only months later in real revenue data.
When to Worry About Type II Errors
- Small sample sizes: studies with fewer than 50 per group are chronically underpowered for detecting anything smaller than a large effect
- Exploratory research where missing effects is costly: if you're screening many ideas and the goal is to avoid killing good ones prematurely
- Competitive contexts: when failing to detect an advantage means a competitor captures it instead
- Go/no-go decisions: when a "no significant difference" result leads to killing a concept rather than further investigation
Common Mistakes
- Not running a power analysis before data collection: the time to discover you're underpowered is before the study, not after
- Interpreting "not significant" as "no effect": non-significance means you didn't detect an effect; it doesn't prove the effect is zero
- Using alpha = 0.01 with a small sample: this combination virtually guarantees you'll miss moderate effects
- Ignoring effect size when reporting null results: if the confidence interval for the difference includes practically meaningful values, the null result is inconclusive, not definitive
- Post-hoc power analysis: calculating power after a study is completed using the observed effect size is circular and uninformative; power analysis is a planning tool
How Quali-Fi Supports Power and Sample Planning
Quali-Fi's Research plan ($1,061/month) includes a built-in sample size calculator that performs power analysis before your study launches. You specify the minimum effect size you want to detect, your desired confidence level, and the platform tells you exactly how many completes you need per cell. This prevents the most common cause of Type II errors: running underpowered studies that can't detect meaningful differences.
Plan your sample size with Quali-Fi
Frequently Asked Questions
How do I know if my non-significant result is a Type II error?
You can't know for certain from a single study. But you can assess the risk. If your study had low power (below 0.80) for the effect size you expected, a non-significant result is inconclusive rather than definitive. Report the confidence interval for the effect, if it includes values that would be practically meaningful, you need a larger sample before concluding the effect doesn't exist.
What's an acceptable Type II error rate?
The standard is β = 0.20 (power = 0.80), meaning you accept a 20% chance of missing a real effect. High-stakes research often uses β = 0.10 or β = 0.05. The right level depends on the cost of missing a real effect versus the cost of collecting more data.
Can I reduce Type II errors without increasing sample size?
Yes, but the options are limited. You can use a more lenient alpha (0.10 instead of 0.05), use a one-tailed instead of two-tailed test if your hypothesis is directional, reduce measurement noise through better survey design, or use a within-subjects design (paired comparisons) instead of between-subjects. Each of these has trade-offs.